Common genetic variants associate with serum phosphorus concentration

Journal of the American Society of Nephrology

Volumn 21, Issue 7, 2010, Pages 1223-1232

  Kestenbaum, Bryan ^a   Glazer, Nicole L ^a   Köttgen, Anna ^a   Felix, Janine F ^a   Hwang, Shih Jen ^a   Liu, Yongmei ^a   Lohman, Kurt ^a   Kritchevsky, Stephen B ^a   Hausman, Dorothy B ^a   Petersen, Ann Kristin ^a   Gieger, Christian ^a   Ried, Janina S ^a   Meitinger, Thomas ^a   Strom, Tim M ^a   Erich Wichmann, H ^a   Campbell, Harry ^a   Hayward, Caroline ^a   Rudan, Igor ^a   De Boer, Ian H ^a   Psaty, Bruce M ^a   Rice, Kenneth M ^a   Chen, Yii Der Ida ^a   Li, Man ^a   Arking, Dan E ^a   Boerwinkle, Eric ^a   Coresh, Josef ^a   Yang, Qiong ^a   Levy, Daniel ^a   Van Rooij, Frank J A ^a   Dehghan, Abbas ^a   Rivadeneira, Fernando ^a   Uitterlinden, AndréG ^a   Hofman, Albert ^a   Van Duijn, Cornelia M ^a   Shlipak, Michael G ^a   Linda Kao, W H ^a   Witteman, Jacqueline C M ^a   Siscovick, David S ^a   Fox, Caroline S ^a   more..

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; FIBROBLAST GROWTH FACTOR 23; PHOSPHATASE; PHOSPHODIESTERASE; PHOSPHORUS; PHOSPHOTRANSFERASE; SODIUM PHOSPHATE COTRANSPORTER 2A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC VARIABILITY; GENOME ANALYSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 77954575665     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111104     Document Type: Article

References (44)

1. Hruska K, Slatopolsky E: Disorders of phosphorous, calcium, and magnesium metabolism. In: Diseases of the kidney, edited by Schrier R, Gottschalk C, London, Little, Brown, and Company, 1996, pp 2477-2526
2. Kronenberg HM: NPT2a - The key to phosphate homeostasis. N Engl J Med 347: 1022-1024, 2002
3. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20: 381-387, 2009
4. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617, 1998 (Pubitemid 28158000)
5. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885, 2007
6. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005
7. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17, 2000
8. Giachelli CM: Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14: S300-S304, 2003
9. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26: 345-348, 2000
10. Bastepe M, Juppner H: Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9: 171-180, 2008
11. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS: Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95: 5372-5377, 1998
12. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113: 561-568, 2004
13. de Boer IH, Rue TC, Kestenbaum B: Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 53: 399-407, 2009
14. Marz W, Seelhorst U, Wellnitz B, Tiran B, Obermayer-Pietsch B, Renner W, Boehm BO, Ritz E, Hoffmann MM: Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality. J Clin Endocrinol Metab 92: 2363-2369, 2007
15. +-Pi cotransport in opossum kidney cells by extracellular phosphate. Am J Physiol 255: C155-C161, 1988
16. Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G: Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347: 983-991, 2002
17. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993
18. Kempson SA, Lotscher M, Kaissling B, Biber J, Murer H, Levi M: Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am J Physiol 268: F784-F791, 1995
19. Birge SJ, Miller R: The role of phosphate in the action of vitamin D on the intestine. J Clin Invest 60: 980-988, 1977
20. Bouillon R, Van Cromphaut S, Carmeliet G: Intestinal calcium absorption: Molecular vitamin D mediated mechanisms. J Cell Biochem 88: 332-339, 2003
21. Armand AS, Pariset C, Laziz I, Launay T, Fiore F, Della Gaspera B, Birnbaum D, Charbonnier F, Chanoine C: FGF6 regulates muscle differentiation through a calcineurin-dependent pathway in regenerating soleus of adult mice. J Cell Physiol 204: 297-308, 2005
22. Liu S, Quarles LD: How fibroblast growth factor 23 works. J Am Soc Nephrol 18: 1637-1647, 2007
23. White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ: The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86: 497-500, 2001
24. Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE: Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146: 4647-4656, 2005
25. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B: Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23: 421-432, 2004
26. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51, 1997
27. Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y: Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 7: 1193-1200, 2007
28. Whyte MP: Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15: 439-461, 1994
29. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Hohne W, Schauer G, Lehmann M, Roscioli T, Schnabel D, Epplen JT, Knisely A, Superti-Furga A, McGill J, Filippone M, Sinaiko AR, Vallance H, Hinrichs B, Smith W, Ferre M, Terkeltaub R, Nurnberg P: Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 34: 379-381, 2003
30. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, Ghoussaini M, Wachter C, Hercberg S, Charpentier G, Patsch W, Pattou F, Charles MA, Tounian P, Clement K, Jouret B, Weill J, Maddux BA, Goldfine ID, Walley A, Boutin P, Dina C, Froguel P: Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 37: 863-867, 2005
31. Saiardi A, Nagata E, Luo HR, Snowman AM, Snyder SH: Identification and characterization of a novel inositol hexakisphosphate kinase. J Biol Chem 276: 39179-39185, 2001
32. Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M: Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19: 615-623, 2008 (Pubitemid 351355405)
33. Psaty B, O'Donnell C, Gudnason V, Lunetta K, Folsom A, Rotter J, Uitterlinden A, Harris T, Witteman JCM, Boerwinkle E: Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2: 73-80, 2009
34. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary D, Psaty B, Rautaharju PM, Tracy R: The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1: 263-276, 1991
35. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP: The Framingham Offspring Study. Design and preliminary data. Prev Med 4: 518-525, 1975
36. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129: 687-702, 1989
37. Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin GP, Kuipers EJ, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC: The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol 24: 553-572, 2009
38. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005
39. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
40. Wichmann HE, Gieger C, Illig T: KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1: S26-S30, 2005
41. Li Y, Ding J, Abecasis G: Mach 1.0: Rapid haplotype reconstruction and missing genotype inference. Presented at the 2006 Annual Meeting of the American Society of Human Genetics, New Orleans, LA, October 9-13, 2006
42. Servin B, Stephens M: Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet 3: 1296-1308, 2007
43. Gordon A, Glazko G, Qiu X, Yakovlev, A: Control of the mean number of false discoveries, Bonferroni and stability of multiple testing. Ann Appl Stat 1: 179-190, 2007
44. Zhong H, Prentice RL: Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. Biostatistics 9: 621-634, 2008